Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Michael Demurjian Sells 20,000 Shares of Stock

Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $1.14, for a total transaction of $22,800.00. Following the sale, the insider now directly owns 26,070,521 shares in the company, valued at $29,720,393.94. The sale was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Michael Demurjian also recently made the following trade(s):

  • On Monday, November 25th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.13, for a total value of $22,600.00.
  • On Monday, November 18th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.09, for a total value of $21,800.00.
  • On Monday, November 11th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.16, for a total value of $23,200.00.
  • On Monday, November 4th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.27, for a total transaction of $25,400.00.
  • On Monday, October 28th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.36, for a total transaction of $27,200.00.
  • On Monday, October 21st, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.40, for a total transaction of $28,000.00.
  • On Monday, October 14th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $92.98, for a total value of $1,859,600.00.
  • On Monday, October 7th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.35, for a total value of $27,000.00.
  • On Tuesday, October 1st, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.42, for a total value of $28,400.00.
  • On Monday, September 23rd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.67, for a total value of $33,400.00.

NASDAQ TYME opened at $1.12 on Wednesday. The company has a market capitalization of $126.50 million, a price-to-earnings ratio of -3.50 and a beta of 0.34. Tyme Technologies Inc has a twelve month low of $0.92 and a twelve month high of $4.64. The stock has a fifty day simple moving average of $1.25 and a 200 day simple moving average of $1.24.

Tyme Technologies (NASDAQ:TYME) last issued its quarterly earnings results on Monday, November 4th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.02. Sell-side analysts anticipate that Tyme Technologies Inc will post -0.21 earnings per share for the current year.

A number of research firms recently weighed in on TYME. Zacks Investment Research upgraded Tyme Technologies from a “hold” rating to a “buy” rating and set a $1.50 price target on the stock in a research note on Friday, November 8th. HC Wainwright started coverage on shares of Tyme Technologies in a research report on Monday, August 12th. They issued a “buy” rating on the stock. Finally, ValuEngine upgraded shares of Tyme Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd.

Institutional investors have recently bought and sold shares of the stock. Squarepoint Ops LLC bought a new stake in shares of Tyme Technologies during the third quarter valued at approximately $71,000. Morgan Stanley raised its holdings in Tyme Technologies by 187.8% during the second quarter. Morgan Stanley now owns 139,579 shares of the company’s stock valued at $170,000 after acquiring an additional 91,081 shares during the period. Perkins Capital Management Inc. raised its position in shares of Tyme Technologies by 77.0% during the third quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock valued at $170,000 after buying an additional 62,000 shares during the last quarter. Paloma Partners Management Co purchased a new position in shares of Tyme Technologies in the second quarter worth $238,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Tyme Technologies by 5.9% during the second quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock worth $374,000 after acquiring an additional 17,173 shares during the last quarter. 12.93% of the stock is currently owned by institutional investors.

Tyme Technologies Company Profile

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Read More: What is the NASDAQ Stock Market?

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit